BaCognize® (Bacopa monnieri — Verdure Sciences)

Bacopa monnieri
Evidence Level
Strong
2 Clinical Trials
5 Documented Benefits
4/5 Evidence Score

BaCognize® is a STANDARDIZED BACOPA MONNIERI EXTRACT developed by Verdure Sciences — distinguished by standardization to 12% bacosides and clinical evidence for cognitive applications. Bacopa is a foundational AYURVEDIC NOOTROPIC herb. Verdure's branded form for cognitive health support. Used for: memory, learning, cognitive function, anxiety reduction, age-related cognitive support.

Studied Dose 300 mg/day BaCognize (research-validated dose)
Active Compound Bacopa monnieri standardized to 12% bacosides

Benefits

Memory and Learning Improvements

Multiple BaCognize trials including the foundational Calabrese 2008 study showed improvements in cognitive performance, memory acquisition, and visual information processing in older adults.

Working Memory Support

Modulates working memory capacity in elderly populations and cognitive aging contexts.

Reduced Anxiety / Cognitive Anxiety Reduction

Bacopa documented to reduce anxiety markers in clinical trials; particularly relevant where cognitive performance is impaired by anxiety.

Information Processing Speed

Improvements in delayed recall and information processing in clinical trials of older adults.

Standardized 12% Bacosides

Verdure's BaCognize standardized to 12% bacosides — specific clinical research backing this standardization.

Mechanism of action

1

Bacoside Cognitive Activity

Bacosides are saponin compounds; cross blood-brain barrier; modulate cholinergic, serotonergic, GABAergic pathways.

2

Acetylcholinesterase Modest Inhibition

Modest AChE inhibition supports cholinergic transmission relevant to memory.

3

BDNF and Synaptic Plasticity

Increases BDNF — supports synaptic plasticity; foundation of learning and memory.

4

Antioxidant Brain Protection

Reduces oxidative stress in brain tissue.

5

GABAergic Anxiolytic

GABA pathway modulation contributes to anxiety reduction.

Clinical trials

1
BaCognize for Cognitive Function — Calabrese 2008
PubMed

12-week RCT of BaCognize 300 mg/day in 54 community-dwelling adults aged 65+.

54 community-dwelling adults aged 65+.

Improvements in delayed word recall, anxiety, depression markers vs placebo. Established BaCognize cognitive evidence in older adults.

2
BaCognize for Working Memory — Subsequent Trials

Subsequent BaCognize trials on cognitive function and working memory.

Older adults across studies.

Cognitive performance improvements; memory and learning support.

About this ingredient

About the active ingredient

BACOGNIZE® is a STANDARDIZED BACOPA MONNIERI EXTRACT developed by VERDURE SCIENCES. BACOPA BACKGROUND: also called BRAHMI; foundational Ayurvedic medhya rasayana (cognitive rejuvenative); 3,000+ years of traditional use.

KEY DISTINCTIONS: (1) STANDARDIZED to 12% bacosides; (2) Verdure clinical research backing; (3) Specific Calabrese 2008 elderly population trial; (4) Verdure quality.

EVIDENCE-BASED USES: (1) Memory and learning (older adults); (2) Working memory; (3) Anxiety reduction; (4) Information processing; (5) Age-related cognitive support.

CRITICAL CAUTIONS: (1) DURATION — bacopa effects build over 8-12 weeks; not immediate; (2) DOSE — 300 mg/day BaCognize research-validated; (3) PREGNANCY — limited safety data; AVOID; (4) BACOGNIZE vs BACOPIN (Sabinsa) — both branded bacopa with clinical evidence; different standardizations; both work; (5) FOR COGNITIVE HEALTH — bacopa among most evidence-based traditional cognitive ingredients; (6) ELDERLY POPULATIONS — particularly relevant evidence from Calabrese 2008; (7) BRAND VERIFICATION — BaCognize® is Verdure Sciences trademark; specific Bacopa standardization; clinical evidence on this branded form; (8) For COMPREHENSIVE COGNITIVE HEALTH — exercise, sleep, social engagement, learning, supplements adjunct.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
Mild GI distress (most common).
Dry mouth.
Drowsiness (relevant for evening use timing).
Allergic reactions rare.

Important Drug interactions

Sedatives — additive sedation possible.
Thyroid medications — bacopa thyrotropic activity; theoretical interactions.
Anticholinergics — opposite effects; theoretical antagonism.
Diabetes medications — modest hypoglycemic effects.
Pregnancy — limited safety data; AVOID.
Lactation — limited data.
Anti-seizure medications — theoretical interactions.

Frequently asked questions about BaCognize® (Bacopa monnieri — Verdure Sciences)

What is the recommended dosage of BaCognize® (Bacopa monnieri — Verdure Sciences)?

The clinically studied dose for BaCognize® (Bacopa monnieri — Verdure Sciences) is 300 mg/day BaCognize (research-validated dose). Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is BaCognize® (Bacopa monnieri — Verdure Sciences) used for?

BaCognize® (Bacopa monnieri — Verdure Sciences) is studied for memory and learning improvements, working memory support, reduced anxiety / cognitive anxiety reduction. Multiple BaCognize trials including the foundational Calabrese 2008 study showed improvements in cognitive performance, memory acquisition, and visual information processing in older adults.

Are there side effects from taking BaCognize® (Bacopa monnieri — Verdure Sciences)?

Reported potential side effects may include: Generally well-tolerated. Mild GI distress (most common). Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does BaCognize® (Bacopa monnieri — Verdure Sciences) interact with medications?

Known drug interactions may include: Sedatives — additive sedation possible. Thyroid medications — bacopa thyrotropic activity; theoretical interactions. Consult a pharmacist or healthcare provider if you take prescription medications.

Is BaCognize® (Bacopa monnieri — Verdure Sciences) good for cognitive?

Yes, BaCognize® (Bacopa monnieri — Verdure Sciences) is researched for Cognitive support. Multiple BaCognize trials including the foundational Calabrese 2008 study showed improvements in cognitive performance, memory acquisition, and visual information processing in older adults.